• market

  PRIVATE

• industry

  Biotechnology

• website

  www.progentos.com

Progentos Therapeutics is developing regenerative medicines for chronic diseases, focusing on a new approach to treating multiple sclerosis that stimulates the body's natural repair mechanisms.